Global Cancer Summit Unveils AI-Driven Targeted mRNA Immunotherapy Protocols

Oncology researchers convening in London during Global Cancer Week announced historic Phase III trial results for personalized mRNA immunotherapies, achieving transformative clinical outcomes against previously untreatable advanced carcinomas.